Complete Filing Data
Spyre Therapeutics, Inc. reported Net Income Loss of -$155.20 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Spyre Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$155.2M | -$208.0M | -$338.8M | -$83.8M | -$65.8M | -$80.9M | -$78.3M | -$44.3M | -$27.2M | -$21.7M | -$11.3M | -$10.3M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $711.0K | -$126.0K | $313.0K | $7.0K | -$30.0K | -$59.0K | $78.0K | $75.0K | -$98.0K | -$3.0K | -$1.0K | |
| Operating Income Loss | -$209.6M | -$208.6M | -$242.3M | -$84.8M | -$65.6M | -$81.5M | -$80.3M | -$45.5M | -$27.7M | -$21.9M | -$11.3M | -$8.9M |
| Operating Expenses | $209.6M | $208.6M | $243.2M | $87.1M | $84.4M | $81.5M | $80.3M | $49.4M | $32.9M | $26.5M | $17.4M | $8.9M |
| Nonoperating Income Expense | $54.3M | $599.0K | -$96.5M | $830.0K | -$11.0K | $588.0K | $2.1M | $1.1M | $440.0K | $208.0K | $20.0K | -$1.4M |
| General And Administrative Expense | $47.9M | $45.8M | $39.9M | $28.5M | $27.3M | $21.8M | $15.7M | $12.6M | $10.1M | $8.4M | $5.9M | $2.1M |
| Comprehensive Income Net Of Tax | -$154.5M | -$208.1M | -$338.4M | -$83.8M | -$65.8M | -$80.9M | -$78.2M | -$44.3M | -$27.3M | -$21.7M | -$11.3M | -$10.3M |
| Other Nonoperating Income Expense | $29.5M | -$20.7M | -$19.1M | -$7.0K | -$122.0K | -$5.0K | -$63.0K | -$57.0K | -$42.0K | -$36.0K | -$2.0K | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$22.0K | $4.0K | $37.0K | -$35.0K | -$1.0K | $19.0K | $0.00 | |||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $886.0K | $2.3M | $18.7M | $0.00 | $0.00 | $3.9M | $5.2M | $4.6M | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$155.2M | -$208.0M | -$338.8M | -$84.0M | -$65.7M | -$80.9M | -$78.3M | |||||
| Income Tax Expense Benefit | -$15.0K | $51.0K | -$26.0K | -$136.0K | $141.0K | $0.00 | $0.00 | |||||
| Research And Development Expense | $58.6M | $57.1M | $59.6M | $64.6M | $36.7M | $22.8M | $18.1M | $11.5M | $6.8M | |||
| Research And Development Expense Excluding Acquired In Process Cost | $171.7M | $162.8M | $89.5M | $58.6M | $57.1M | |||||||
| Acquired In Process Research And Development | $0.00 | $0.00 | $130.2M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$11.2M | -$36.7M | -$44.8M | -$69.0M | -$38.8M | -$43.9M | -$40.1M | -$217.1M | -$18.4M | -$18.2M | -$22.3M | -$24.4M | -$20.3M | -$6.8M | -$18.2M | -$22.7M | -$18.0M | -$21.4M | -$18.7M | -$21.5M | -$21.6M | -$18.0M | -$17.2M | -$14.9M | -$11.9M | -$9.4M | -$8.1M | -$6.5M | -$7.9M | -$6.6M | -$6.2M | -$5.5M | -$6.2M | -$5.4M | -$4.5M | -$4.0M | -$3.4M | -$1.4M | -$2.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $337.0K | -$192.0K | $488.0K | $2.0M | -$194.0K | -$681.0K | -$114.0K | -$1.0K | $32.0K | $74.0K | -$31.0K | -$120.0K | $1.0K | -$16.0K | $10.0K | -$24.0K | $173.0K | -$185.0K | $11.0K | $54.0K | $40.0K | $23.0K | $42.0K | $4.0K | -$3.0K | $8.0K | -$33.0K | $2.0K | -$2.0K | $4.0K | $2.0K | ||||||||
| Operating Income Loss | -$56.9M | -$41.9M | -$53.6M | -$55.4M | -$44.1M | -$47.8M | -$18.3M | -$159.2M | -$18.8M | -$18.8M | -$22.4M | -$24.4M | -$20.3M | -$6.7M | -$18.2M | -$22.8M | -$18.1M | -$21.6M | -$19.0M | -$21.9M | -$22.1M | -$18.6M | -$17.7M | -$15.3M | -$12.2M | -$9.7M | -$8.2M | -$6.6M | -$8.0M | -$6.7M | -$6.3M | -$5.5M | -$6.3M | -$5.5M | -$4.6M | -$4.0M | -$3.4M | -$1.4M | -$2.5M |
| Operating Expenses | $56.9M | $41.9M | $53.6M | $55.4M | $44.1M | $47.8M | $18.3M | $159.9M | $19.0M | $18.9M | $23.0M | $25.8M | $21.7M | $20.4M | $18.2M | $18.1M | $21.6M | $19.0M | $22.1M | $18.6M | $17.7M | $12.2M | $12.0M | $9.8M | $9.3M | $8.2M | $7.3M | $7.5M | $6.9M | $5.4M | $4.5M | $4.9M | $2.5M | ||||||
| Nonoperating Income Expense | $45.7M | $5.2M | $8.8M | -$13.6M | $5.3M | $3.9M | -$21.8M | -$57.8M | $348.0K | $312.0K | $109.0K | $5.0K | $12.0K | -$33.0K | -$9.0K | $90.0K | $142.0K | $294.0K | $573.0K | $603.0K | $490.0K | $326.0K | $256.0K | $126.0K | $124.0K | $88.0K | $84.0K | $63.0K | $65.0K | $20.0K | $4.0K | $5.0K | $1.0K | ||||||
| General And Administrative Expense | $11.6M | $11.8M | $11.9M | $10.6M | $11.5M | $12.8M | $8.6M | $12.1M | $5.2M | $7.0M | $7.7M | $8.8M | $6.8M | $6.8M | $6.4M | $5.7M | $4.7M | $4.5M | $4.3M | $3.8M | $3.3M | $3.3M | $2.9M | $2.9M | $3.0M | $2.4M | $2.4M | $2.1M | $2.4M | $1.8M | $1.4M | $2.1M | $847.0K | ||||||
| Comprehensive Income Net Of Tax | -$10.8M | -$36.9M | -$44.3M | -$67.0M | -$39.0M | -$44.5M | -$40.3M | -$217.1M | -$18.4M | -$18.2M | -$22.4M | -$24.6M | -$20.3M | -$6.8M | -$18.2M | -$18.1M | -$21.2M | -$18.9M | -$21.6M | -$18.0M | -$17.1M | -$11.9M | -$9.4M | -$8.1M | -$7.9M | -$6.6M | -$6.3M | -$6.2M | -$5.4M | -$4.5M | -$3.4M | -$1.4M | -$2.5M | ||||||
| Other Nonoperating Income Expense | $40.3M | -$656.0K | $2.3M | -$18.8M | -$610.0K | -$483.0K | $2.3M | -$8.0K | -$72.0K | $24.0K | $5.0K | -$30.0K | -$24.0K | -$52.0K | -$31.0K | $2.0K | -$19.0K | -$6.0K | -$12.0K | -$16.0K | -$17.0K | -$13.0K | -$7.0K | -$17.0K | -$12.0K | -$12.0K | -$11.0K | -$9.0K | -$9.0K | -$6.0K | -$1.0K | ||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $0.00 | -$36.0K | $14.0K | $17.0K | $4.0K | $16.0K | -$29.0K | $18.0K | $10.0K | -$38.0K | -$36.0K | -$13.0K | -$10.0K | $2.0K | $4.0K | $5.0K | |||||||||||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $688.0K | $198.0K | $174.0K | $625.0K | $1.4M | $1.4M | $13.7M | $0.00 | $0.00 | $0.00 | $0.00 | $2.4M | $1.5M | $1.5M | $1.3M | $1.5M | $982.0K | ||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$11.2M | -$36.7M | -$44.8M | -$69.0M | -$38.8M | -$43.8M | -$40.1M | -$217.1M | -$18.5M | -$18.4M | -$22.3M | -$24.4M | -$20.3M | -$6.7M | -$18.0M | -$21.4M | |||||||||||||||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | -$15.0K | $18.0K | $0.00 | $32.0K | $3.0K | $7.0K | -$36.0K | -$209.0K | $9.0K | $0.00 | $26.0K | $92.0K | |||||||||||||||||||||||||
| Research And Development Expense | $13.8M | $12.0M | $15.4M | $17.0M | $14.9M | $13.6M | $11.9M | $12.5M | $16.9M | $14.6M | $17.8M | $14.8M | $14.4M | $8.9M | $9.1M | $6.9M | $6.2M | $5.8M | $4.9M | $5.4M | $4.4M | $3.6M | $3.1M | $2.7M | $1.6M | ||||||||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $45.2M | $40.1M | $41.6M | $44.7M | $32.6M | $34.9M | $24.7M | $17.4M | $13.8M | $12.0M | $15.4M | ||||||||||||||||||||||||||||
| Acquired In Process Research And Development | $0.00 | $0.00 | -$298.0K | $130.5M | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $715.2M | $517.8M | $184.0M | $50.3M | $83.9M | $139.8M | $60.1M | $67.4M | $50.3M | $63.0M | -$22.2M | -$11.5M | -$1.3M |
| Cash And Cash Equivalents At Carrying Value | $85.7M | $89.4M | $188.9M | $34.9M | $15.1M | $90.1M | $19.3M | $22.5M | $12.8M | $29.3M | $2.6M | $4.6M | |
| Retained Earnings Accumulated Deficit | -$1.13B | -$972.4M | -$764.4M | -$425.6M | -$341.8M | -$276.0M | -$195.1M | -$116.9M | -$72.5M | -$45.3M | -$23.6M | ||
| Prepaid Expense And Other Assets Current | $21.2M | $5.4M | $2.3M | $6.2M | $4.9M | $3.5M | $2.6M | $2.2M | $1.6M | $1.7M | $912.0K | ||
| Other Assets Noncurrent | $0.00 | $10.0K | $9.0K | $683.0K | $842.0K | $115.0K | $67.0K | $50.0K | $232.0K | $40.0K | $20.0K | ||
| Liabilities Current | $58.7M | $54.1M | $32.0M | $14.7M | $20.1M | $16.4M | $18.4M | $10.2M | $5.6M | $4.0M | $2.5M | ||
| Liabilities And Stockholders Equity | $777.8M | $608.5M | $341.9M | $71.1M | $109.9M | $161.6M | $83.2M | $77.7M | $56.1M | $67.1M | $38.7M | ||
| Liabilities | $62.5M | $90.7M | $73.3M | $20.8M | $26.0M | $21.8M | $23.1M | $10.3M | $5.7M | $4.1M | $2.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.7M | -$99.8M | $152.8M | $19.4M | -$75.0M | $71.2M | -$1.7M | $9.6M | -$34.9M | $18.5M | |||
| Assets Current | $777.8M | $608.5M | $341.5M | $62.3M | $98.9M | $149.8M | $74.5M | $76.7M | $55.0M | $66.4M | $38.3M | ||
| Assets | $777.8M | $608.5M | $341.9M | $71.1M | $109.9M | $161.6M | $83.2M | $77.7M | $56.1M | $67.1M | $38.7M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $869.0K | $180.0K | $302.0K | -$48.0K | -$20.0K | $11.0K | $51.0K | -$27.0K | -$102.0K | -$4.0K | -$1.0K | ||
| Accrued Liabilities And Other Liabilities | $26.9M | $27.7M | $13.1M | $12.8M | $14.0M | $13.9M | $14.9M | $9.6M | $5.2M | $3.7M | $2.3M | ||
| Common Stock Value | $15.0K | $13.0K | $10.0K | $6.0K | $5.0K | $5.0K | $3.0K | $2.0K | $2.0K | $1.0K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $8.1M | $11.4M | $2.3M | $327.0K | -$548.0K | -$73.0K | $818.0K | $593.0K | -$75.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $85.7M | $89.4M | $189.2M | $36.4M | $17.0M | $91.9M | |||||||
| Finance Lease Principal Payments | $0.00 | $16.0K | $418.0K | $510.0K | $20.0K | $25.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $91.9M | $20.8M | $22.5M | $12.8M | $47.7M | $29.3M | |||||||
| Property Plant And Equipment Net | $0.00 | $3.2M | $4.5M | $5.6M | $2.4M | $1.0M | $854.0K | $599.0K | $348.0K | ||||
| Available For Sale Securities Debt Securities Current | $670.8M | $513.7M | $150.4M | $20.8M | $78.0M | $56.2M | $52.7M | $52.1M | |||||
| Additional Paid In Capital Common Stock | $1.69B | $1.33B | $763.2M | $476.0M | $425.8M | $415.8M | $255.1M | $184.3M | |||||
| Restricted Cash Noncurrent | $0.00 | $322.0K | $1.6M | $1.8M | $1.8M | $1.5M | |||||||
| Leased Assets Obtained In Exchange For Lease Obligations | $0.00 | $0.00 | $21.0K | $872.0K | $172.0K | $5.3M | |||||||
| Other Liabilities Noncurrent | $0.00 | $16.0K | $214.0K | $31.0K | $72.0K | $111.0K | $132.0K | $27.0K | |||||
| Accounts Payable Current | $3.3M | $2.3M | $3.2M | $663.0K | $389.0K | $168.0K | $176.0K | ||||||
| Operating Lease Liability Noncurrent | $0.00 | $4.0M | $4.6M | $5.1M | $4.7M | ||||||||
| Operating Lease Liability Current | $0.00 | $625.0K | $436.0K | $319.0K | $351.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $455.1M | $455.8M | $482.6M | $327.4M | $374.4M | $152.3M | -$245.4M | -$207.4M | $33.7M | $67.6M | $84.2M | $61.7M | $102.1M | $119.0M | $123.8M | $136.3M | $152.3M | $42.8M | $79.8M | $99.6M | $116.3M | $63.7M | $73.4M | $43.9M | $55.5M | $62.6M | $57.2M | $68.2M | $73.9M | -$26.6M | |||||||
| Cash And Cash Equivalents At Carrying Value | $64.9M | $81.7M | $48.5M | $71.6M | $45.1M | $227.6M | $90.6M | $235.4M | $35.2M | $39.0M | $37.5M | $14.6M | $24.7M | $34.8M | $80.2M | $54.2M | $65.7M | $12.6M | $24.5M | $25.4M | $85.6M | $14.5M | $20.6M | $10.8M | $13.2M | $26.9M | $16.8M | $47.7M | $49.5M | $70.6M | $24.0M | $30.8M | $39.1M | $43.8M | |||
| Retained Earnings Accumulated Deficit | -$1.07B | -$1.05B | -$1.02B | -$916.1M | -$847.1M | -$808.3M | -$701.2M | -$661.1M | -$444.0M | -$406.8M | -$388.6M | -$366.2M | -$321.4M | -$301.1M | -$294.2M | -$253.3M | -$235.3M | -$213.8M | -$173.6M | -$152.0M | -$134.0M | -$102.0M | -$90.0M | -$80.6M | -$66.0M | -$58.2M | -$51.5M | -$39.8M | -$33.6M | -$28.1M | |||||||
| Prepaid Expense And Other Assets Current | $18.4M | $12.3M | $4.9M | $6.9M | $9.7M | $2.6M | $2.2M | $2.9M | $5.6M | $7.9M | $7.6M | $4.9M | $5.1M | $5.8M | $3.3M | $4.4M | $4.1M | $5.3M | $3.9M | $4.4M | $3.1M | $3.2M | $2.4M | $2.0M | $1.3M | $1.6M | $1.5M | $2.1M | $1.6M | $1.3M | |||||||
| Other Assets Noncurrent | $0.00 | $0.00 | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | $10.0K | $78.0K | $749.0K | $752.0K | $800.0K | $897.0K | $1.5M | $716.0K | $122.0K | $92.0K | $60.0K | $114.0K | $120.0K | $749.0K | $49.0K | $49.0K | $133.0K | $139.0K | $139.0K | $140.0K | $40.0K | $18.0K | $18.0K | |||||||
| Liabilities Current | $46.3M | $83.1M | $70.7M | $57.5M | $22.1M | $42.8M | $44.9M | $232.2M | $12.6M | $17.7M | $15.9M | $16.3M | $20.4M | $20.6M | $32.4M | $14.3M | $15.9M | $17.1M | $15.4M | $13.0M | $11.8M | $7.5M | $6.2M | $5.8M | $4.9M | $4.4M | $4.0M | $3.8M | $3.4M | $3.8M | |||||||
| Liabilities And Stockholders Equity | $504.6M | $538.8M | $569.8M | $421.1M | $436.1M | $487.6M | $207.3M | $243.5M | $52.5M | $91.6M | $106.7M | $83.2M | $129.1M | $147.0M | $163.6M | $155.6M | $172.9M | $64.8M | $100.1M | $117.5M | $128.5M | $71.3M | $79.7M | $49.8M | $60.5M | $67.1M | $61.3M | $72.1M | $77.3M | $35.5M | |||||||
| Liabilities | $49.5M | $83.1M | $87.2M | $93.7M | $61.7M | $81.9M | $65.6M | $253.6M | $18.8M | $24.0M | $22.6M | $21.5M | $27.0M | $28.0M | $39.9M | $19.4M | $20.7M | $22.0M | $20.3M | $17.9M | $12.2M | $7.6M | $6.3M | $5.9M | $5.0M | $4.5M | $4.1M | $3.9M | $3.4M | $3.8M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$40.9M | $38.7M | $137.0K | -$515.0K | -$9.9M | -$6.7M | $63.2M | -$2.1M | |||||||||||||||||||||||||||||
| Assets Current | $504.6M | $538.8M | $569.8M | $421.1M | $435.7M | $487.3M | $205.9M | $239.9M | $44.4M | $82.2M | $96.6M | $72.6M | $117.5M | $134.4M | $151.4M | $144.4M | $161.9M | $54.3M | $92.6M | $109.9M | $126.8M | $70.4M | $78.9M | $48.8M | $59.5M | $66.2M | $60.3M | $71.7M | $76.9M | $35.2M | |||||||
| Assets | $504.6M | $538.8M | $569.8M | $421.1M | $436.1M | $487.6M | $207.3M | $243.5M | $52.5M | $91.6M | $106.7M | $83.2M | $129.1M | $147.0M | $163.6M | $155.6M | $172.9M | $64.8M | $100.1M | $117.5M | $128.5M | $71.3M | $79.7M | $49.8M | $60.5M | $67.1M | $61.3M | $72.1M | $77.3M | $35.5M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $791.0K | $454.0K | $682.0K | $1.5M | -$553.0K | -$363.0K | -$132.0K | $11.0K | -$6.0K | -$184.0K | -$220.0K | -$153.0K | $2.0K | $11.0K | $25.0K | $20.0K | $39.0K | -$134.0K | $78.0K | $67.0K | $13.0K | -$33.0K | -$56.0K | -$98.0K | -$32.0K | -$29.0K | -$37.0K | $3.0K | $1.0K | $3.0K | |||||||
| Accrued Liabilities And Other Liabilities | $23.8M | $19.4M | $21.6M | $13.2M | $5.7M | $21.6M | $15.9M | $28.4M | $9.7M | $12.4M | $13.1M | $10.8M | $13.4M | $12.4M | $11.0M | $11.7M | $11.5M | $13.2M | $12.7M | $10.0M | $8.3M | $6.4M | $5.2M | $5.0M | $4.2M | $3.7M | $3.6M | $3.1M | $3.0M | $3.3M | |||||||
| Common Stock Value | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $10.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $0.00 | $0.00 | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.6M | $2.4M | $107.0K | -$15.0K | -$181.0K | $48.0K | $275.0K | $14.0K | |||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $64.9M | $81.7M | $48.5M | $71.6M | $45.5M | $227.9M | $91.9M | $236.7M | $36.6M | $40.5M | |||||||||||||||||||||||||||
| Finance Lease Principal Payments | $0.00 | $8.0K | $172.0K | $5.0K | $7.0K | $6.0K | |||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $236.7M | $36.6M | $36.4M | $40.5M | $39.3M | $16.5M | $17.0M | $26.5M | $36.6M | $82.1M | $55.7M | $67.2M | $14.1M | $26.0M | $26.9M | $85.6M | $14.5M | $20.6M | $10.8M | $13.2M | |||||||||||||||||
| Property Plant And Equipment Net | $0.00 | $0.00 | $3.4M | $3.6M | $3.9M | $4.2M | $4.9M | $5.2M | $5.5M | $5.2M | $4.9M | $4.2M | $980.0K | $921.0K | $952.0K | $846.0K | $776.0K | $810.0K | $844.0K | $802.0K | $822.0K | $342.0K | $377.0K | $321.0K | |||||||||||||
| Available For Sale Securities Debt Securities Current | $421.3M | $444.9M | $516.3M | $342.6M | $380.9M | $257.1M | $113.0M | $0.00 | $3.2M | $34.7M | $51.1M | $52.1M | $87.8M | $93.8M | $46.4M | $85.8M | $92.0M | $36.4M | $64.2M | $80.1M | |||||||||||||||||
| Additional Paid In Capital Common Stock | $1.36B | $1.35B | $1.34B | $1.09B | $1.07B | $776.0M | $456.0M | $453.7M | $477.7M | $474.5M | $472.9M | $428.1M | $423.4M | $420.1M | $418.0M | $389.5M | $387.5M | $256.8M | $253.3M | $251.6M | |||||||||||||||||
| Restricted Cash Noncurrent | $0.00 | $321.0K | $319.0K | $1.3M | $1.3M | $1.3M | $1.5M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | ||||||||||||||||||||
| Leased Assets Obtained In Exchange For Lease Obligations | $137.0K | $776.0K | |||||||||||||||||||||||||||||||||||
| Other Liabilities Noncurrent | $0.00 | $0.00 | $8.0K | $192.0K | $200.0K | $206.0K | $61.0K | $68.0K | $23.0K | $38.0K | $45.0K | $52.0K | $81.0K | $91.0K | $101.0K | $117.0K | $122.0K | $127.0K | $26.0K | $16.0K | $22.0K | ||||||||||||||||
| Accounts Payable Current | $2.9M | $2.1M | $677.0K | $4.2M | $2.0M | $3.0M | $1.9M | $2.2M | $1.9M | $2.3M | $4.2M | $3.6M | $2.4M | $2.7M | $3.2M | $1.1M | $952.0K | $763.0K | $615.0K | $634.0K | $267.0K | $523.0K | $348.0K | $509.0K | |||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $0.00 | $3.8M | $4.2M | $4.3M | $4.5M | $4.7M | $4.9M | $5.0M | $4.9M | $4.7M | $4.8M | $4.9M | $4.8M | $372.0K | ||||||||||||||||||||||
| Operating Lease Liability Current | $0.00 | $4.3M | $608.0K | $587.0K | $477.0K | $457.0K | $415.0K | $412.0K | $315.0K | $341.0K | $228.0K | $293.0K | $289.0K | $328.0K | $317.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $309.0M | $410.9M | $361.1M | $42.7M | $1.4M | $154.5M | $65.7M | $57.1M | $12.2M | $49.4M | $41.7M | $5.6M |
| Investing Cash Flow * | -$143.5M | -$353.3M | -$108.4M | $57.0M | -$22.6M | -$7.6M | -$1.7M | -$15.2M | -$22.5M | -$12.1M | -$4.0M | -$221.0K |
| Operating Cash Flow * | -$169.3M | -$157.4M | -$99.9M | -$80.1M | -$53.7M | -$75.8M | -$65.7M | -$32.2M | -$24.6M | -$18.8M | -$11.0M | -$7.3M |
| Stock Issued During Period Value Share Based Compensation | $37.6M | $30.4M | $14.3M | $7.1M | $8.0M | $6.3M | $4.9M | $4.3M | $2.5M | $1.2M | $20.0K | $147.0K |
| Share Based Compensation | $37.6M | $44.8M | $25.7M | $7.1M | $8.0M | $6.3M | $4.9M | $4.3M | $2.5M | $1.2M | $767.0K | $147.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $12.8M | $2.9M | -$3.2M | $1.1M | $1.2M | $1.1M | $346.0K | $261.0K | $114.0K | $924.0K | $586.0K | $112.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$764.0K | $14.6M | -$4.9M | -$843.0K | -$373.0K | -$1.1M | $5.1M | $4.2M | $1.7M | $1.8M | $1.1M | $303.0K |
| Depreciation Depletion And Amortization | $0.00 | $0.00 | $744.0K | $1.6M | $1.6M | $996.0K | $418.0K | $293.0K | $249.0K | $132.0K | $89.0K | $19.0K |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 3.3M | 7.5M | 405.0K | 222.0K | 1.9M | 816.0K | 1.5M | 3.0M | 833.0K | 76.0K | 23.0K | |
| Payments To Acquire Property Plant And Equipment | $0.00 | $0.00 | $38.0K | $573.0K | $4.3M | $1.5M | $422.0K | $619.0K | $212.0K | $208.0K | $181.0K | |
| Increase Decrease In Accounts Receivable | $0.00 | $0.00 | -$375.0K | -$440.0K | $815.0K | $0.00 | $0.00 | -$3.1M | $1.9M | -$482.0K | $1.7M | |
| Proceeds From Sale And Maturity Of Available For Sale Securities | $371.7M | $246.0M | $39.9M | $96.5M | $111.0M | $125.7M | $91.7M | $47.4M | $42.2M | |||
| Payments To Acquire Available For Sale Securities Debt | $522.2M | $599.3M | $166.8M | $39.5M | $133.1M | $129.0M | $91.9M | $62.2M | $64.1M | |||
| Increase Decrease In Contract With Customer Liability | $0.00 | $0.00 | $575.0K | -$880.0K | $3.6M | $0.00 | $0.00 | -$20.0K | -$51.0K | $71.0K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | -$3.0K | $25.0K | -$106.0K | -$15.0K | $51.0K | $0.00 | |||||
| Increase Decrease In Accounts Payable | -$2.6M | $1.1M | -$544.0K | $2.6M | $239.0K | $164.0K | -$8.0K | -$169.0K | -$165.0K | |||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Public Offering Net Of Offering Costs | $1.0K | $0.00 | $42.9M | $0.00 | $153.7M | $64.3M | $54.0M | $11.4M | ||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $0.00 | $475.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $125.0K | $172.2M | $10.0K | $12.0K | $362.0K | $282.0K | $65.1M | $688.0K | $96.0K | -$98.0K | $43.7M | ||||||||||||||||
| Investing Cash Flow * | -$61.0K | -$105.0M | $17.8M | $25.8M | $9.3M | $14.8M | $13.9M | $4.7M | -$25.6M | -$1.2M | -$20.0K | ||||||||||||||||
| Operating Cash Flow * | -$41.0M | -$28.5M | -$17.6M | -$26.3M | -$19.5M | -$21.7M | -$15.8M | -$7.4M | -$5.4M | -$4.0M | -$2.5M | ||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $9.6M | $9.4M | $8.9M | $7.0M | $7.2M | $8.4M | $2.1M | $1.8M | $1.7M | $1.6M | $2.0M | $2.1M | $2.1M | $2.1M | $1.8M | $1.7M | $1.6M | $1.3M | $1.4M | $1.2M | $1.1M | $1.1M | $996.0K | $835.0K | |||
| Share Based Compensation | $8.9M | $13.1M | $8.7M | $13.8M | $4.8M | $1.9M | $1.7M | $2.1M | $1.8M | $1.3M | $1.1M | $835.0K | $401.0K | $140.0K | $38.0K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$462.0K | $381.0K | -$622.0K | -$150.0K | $340.0K | $2.7M | $928.0K | $102.0K | -$151.0K | $431.0K | $180.0K | ||||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$6.0M | $8.2M | -$3.2M | -$3.1M | -$2.7M | -$2.1M | -$1.1M | -$217.0K | -$87.0K | $475.0K | -$74.0K | ||||||||||||||||
| Depreciation Depletion And Amortization | $0.00 | $384.0K | $403.0K | $355.0K | $154.0K | $100.0K | $70.0K | $52.0K | $29.0K | $17.0K | |||||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 335.0K | 4.4M | 18.0K | 184.0K | 367.0K | 289.0K | 399.0K | 688.0K | 96.0K | ||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $37.0K | $450.0K | $1.4M | $118.0K | $83.0K | $271.0K | $2.0K | $10.0K | |||||||||||||||||||
| Increase Decrease In Accounts Receivable | $0.00 | -$45.0K | $197.0K | $21.5M | $295.0K | -$234.0K | -$79.0K | ||||||||||||||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $71.4M | $47.8M | $17.8M | $29.3M | $34.0M | $20.1M | $33.8M | ||||||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $71.4M | $152.7M | $0.00 | $3.5M | $24.3M | $4.0M | $19.8M | ||||||||||||||||||||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$53.0K | -$767.0K | $21.5M | -$20.0K | ||||||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | -$4.0K | $11.0K | -$23.0K | $7.0K | ||||||||||||||||||||||
| Increase Decrease In Accounts Payable | $1.4M | -$338.0K | -$376.0K | $262.0K | $2.3M | $396.0K | $95.0K | $261.0K | -$18.0K | ||||||||||||||||||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Public Offering Net Of Offering Costs | $64.7M | ||||||||||||||||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $500.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$49.12 | -$24.86 | -$25.02 | -$1.52 | -$2.45 | -$2.13 | -$1.80 | -$2.22 | -$19.21 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 400.0M | 400.0M | 20.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 25.0M | |
| Common Stock Shares Issued | 78.2M | 60.3M | 36.1M | 2.6M | 49.4M | 48.0M | 29.1M | 24.1M | 16.7M | 13.4M | 757.3K |
| Common Stock Shares Outstanding | 78.2M | 60.3M | 36.1M | 2.6M | 49.4M | 48.0M | 29.1M | 24.1M | 16.7M | 13.4M | 757.3K |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Weighted Average Number Of Shares Outstanding Basic | 6.9M | 3.4M | 2.6M | 53.4M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 6.9M | 3.4M | 2.6M | 53.4M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Earnings Per Share Basic | $-49.12 | $-24.86 | $-25.02 | $-1.52 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 65.7M | 53.4M | 31.9M | 20.8M | 15.1M | 9.8M | 599.8K | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.36 | -$0.86 | -$1.20 | -$9.34 | -$56.79 | -$4.89 | -$4.84 | -$0.27 | -$0.37 | -$0.31 | -$0.10 | -$0.28 | -$0.35 | -$0.29 | -$0.40 | -$0.57 | -$0.65 | -$0.66 | -$0.55 | -$0.59 | -$0.62 | -$0.54 | -$0.46 | -$0.49 | -$0.39 | -$0.48 | -$0.47 | -$0.47 | -$0.41 | -$0.47 | -$0.46 | -$7.10 | -$6.36 | -$5.57 | -$2.44 | -$4.71 | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 20.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||||||||||
| Common Stock Shares Issued | 60.5M | 60.4M | 60.3M | 51.4M | 50.8M | 36.6M | 4.0M | 81.0M | 65.4M | 61.5M | 61.2M | 49.4M | 49.3M | 49.0M | 49.0M | 44.7M | 44.6M | 29.1M | 28.9M | 28.8M | 28.8M | 22.1M | 21.9M | 16.8M | 16.5M | 16.5M | 13.5M | 13.4M | 13.4M | 757.3K | |||||||||||
| Common Stock Shares Outstanding | 60.5M | 60.4M | 60.3M | 51.4M | 50.8M | 36.6M | 4.0M | 81.0M | 65.4M | 61.5M | 61.2M | 49.4M | 49.3M | 49.0M | 49.0M | 44.7M | 44.6M | 29.1M | 28.9M | 28.8M | 28.8M | 22.1M | 21.9M | 16.8M | 16.5M | 16.5M | 13.5M | 13.4M | 13.4M | 757.3K | |||||||||||
| Preferred Stock Shares Authorized | 8.6M | 8.8M | 8.9M | 8.9M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 50.9M | 45.3M | 36.5M | 4.3M | 3.8M | 3.8M | 3.8M | 82.2M | 66.0M | 65.8M | 65.6M | ||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 50.9M | 45.3M | 36.5M | 4.3M | 3.8M | 3.8M | 3.8M | 82.2M | 66.0M | 65.8M | 65.6M | ||||||||||||||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Earnings Per Share Basic | $-1.36 | $-0.86 | $-1.20 | $-9.34 | $-56.79 | $-4.89 | $-4.84 | $-0.27 | $-0.37 | $-0.31 | $-0.10 | ||||||||||||||||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 66.0M | 65.8M | 65.6M | 65.6M | 62.2M | 52.9M | 33.1M | 32.9M | 32.8M | 29.0M | 22.0M | 20.6M | 16.7M | 16.4M | 14.1M | 13.4M | 13.3M | 11.8M | 640.7K | 612.9K | 585.8K | 573.2K | |||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Net | $24.9M | $21.3M | $6.1M | $837.0K | $111.0K | $593.0K | $2.1M | $1.2M | $482.0K | $244.0K | $22.0K | $1.0K |
| Other Noncash Income Expense | $0.00 | $0.00 | -$15.0K | -$426.0K | $335.0K | $9.0K | $5.0K | $40.0K | $21.0K | $10.0K | $19.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $222.0K | $454.0K | $366.0K | $307.0K | $207.0K | $131.0K | $76.0K | |||||
| Stock Issued During Period Value Stock Options Exercised | $1.4M | $490.0K | $1.1M | $2.8M | $702.0K | $23.0K | ||||||
| Disposal Group Not Discontinued Operation Gain Loss On Disposal | $10.0M | $0.00 | $16.4M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Net | $5.4M | $5.9M | $6.5M | $5.2M | $5.9M | $4.4M | $1.3M | $350.0K | $420.0K | $288.0K | $104.0K | $35.0K | $36.0K | $19.0K | $22.0K | $88.0K | $161.0K | $300.0K | $585.0K | $619.0K | $507.0K | $339.0K | $263.0K | $143.0K | $136.0K | $100.0K | $95.0K | $72.0K | $74.0K | $26.0K | $5.0K | $5.0K | $1.0K |
| Other Noncash Income Expense | $0.00 | -$2.0K | -$2.0K | $0.00 | -$69.0K | $11.0K | $5.0K | ||||||||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $18.0K | $38.0K | $184.0K | $230.0K | $224.0K | $192.0K | $174.0K | $164.0K | $143.0K | $129.0K | $78.0K | ||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $1.0M | $33.0K | $146.0K | $219.0K | $44.0K | $115.0K | $212.0K | $46.0K | $261.0K | $927.0K | $248.0K | $785.0K | |||||||||||||||||||||
| Disposal Group Not Discontinued Operation Gain Loss On Disposal | $0.00 | $10.0M | $0.00 | $0.00 | $14.6M | $0.00 |
Most recent annual filing with the SEC: February 19, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.